Quasar MD Plus — FDA-Cleared Red Light for Skin

A clinically-cited, FDA-cleared red light device with 20+ years of brand history in dermatology offices — now at a home-use price point ($249-399).

Quasar MD Plus is the home-use descendant of devices originally built for dermatologist offices in the 2000s. The brand has been cited in published photobiomodulation research and clinical skin-health protocols longer than most home red-light competitors have existed — Joovv launched in 2015, Bon Charge in 2018, NovaaLab in 2018. Quasar started in 2010 with a longer-running clinical pedigree.

The product is purpose-built for face-focused PBM: collagen stimulation, fine-line softening, inflammation reduction. The open-air design keeps the skin cool during sessions (most LED face masks trap heat), and the FDA-cleared dual-wavelength architecture (red + infrared) targets the dermal layer where the published collagen research lives. Sessions are 10 minutes per zone, 3-5 times per week.

Where it competes: this is a meaningfully different product than a Joovv panel or NovaaLab Light Pad. Those are systemic-PBM tools (whole-body or large-zone protocols). Quasar MD Plus is a face-specific device — the same category as Bon Charge SkinShield Pro ($499-799), CurrentBody LED Mask ($395), and Therabody TheraFace Pro ($399). At $249-399 it slots in as the value-tier option in the face-PBM category, with the longest clinical-citation lineage of any brand in the comparison.

Where it gives ground: this is not a full-body solution. If you want PBM for sleep, mood, mitochondrial work, or large-tissue recovery, a panel (Joovv) or pad (NovaaLab) is the right answer. Quasar's value is specifically face + neck + décolletage skin work.

The LV-relevant signal: $0.94 EPC at 2.56% conversion. Lower-EPC than NovaaLab but the funnel is honest — buyers who land on the Quasar page know they're shopping face-PBM specifically and either commit or bounce cleanly.

Specifications

Most often compared with